BackMicrobot Medical Overview

Microbot Medical Receivables

Microbot Medical's receivables is $180K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$176000.00

Peer trimmed avg / median

Loading

Microbot Medical Receivables History

Loading

Microbot Medical vs. peers: Receivables Comparison

Loading

Microbot Medical Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Microbot Medical (MBOT) FAQ

Microbot Medical (MBOT) currently reports a receivables of $180K as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Microbot Medical's receivables history and peer comparisons.

Microbot Medical's receivables changed from $0 to $180K (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Microbot Medical reported $180K in receivables as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $180K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Microbot Medical, and consider following MBOT for alerts when major investors trade the stock.

Microbot Medical is classified in the Healthcare sector. On receivables, it currently shows $180K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MBOT with unrelated industries.